본문 바로가기
KERD
논문KCI 등재

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment

김용구|Bun-Hee Lee
대한신경정신의학회 (Korean Neuropsychiatric Association)|2010.12|PSYCHIATRY INVESTIGATION|제7권 제4호|pp. 231-235

2

조회

0

다운로드

8

인용

0

참고문헌

키워드

DepressionNeuroplasticityBrain-derived neurotrophic factorAntidepressant.
주제분류정신과학

초록

Neurotrophic factors are critical regulators of the formation and plasticity of neuronal networks. Brain-derived neurotrophic factor (BD-NF) is abundant in the brain and periphery, and is found in both human serum and plasma. Animal studies have demonstrated that stress reduces BDNF expression or activity in the hippocampus and that this reduction can be prevented by treatment with antidepressant drugs. A similar change in BDNF activity occurs in the brain of patients with major depression disorder (MDD). Recently, clinical studies have indicated that serum or plasma BDNF levels are decreased in untreated MDD patients. Antidepressant treatment for at least four weeks can restore the decreased BDNF function up to the normal value. Therefore, MDD is associated with impaired neuronal plasticity. Suicidal behavior can be a consequence of severe impaired neuronal plasticity in the brain. Antidepressant treatment promotes increased BDNF activity as well as several forms of neuronal plasticity, including neurogenesis, synaptogenesis and neuronal maturation. BDNF could also play an important role in the modulation of neuronal networks. Such a neuronal plastic change can positively influence mood or recover depressed mood. These alterations of BDNF levels or neuronal plasticity in MDD patients before and after antidepressant treatment can be measured through the examination of serum or plasma BDNF concentrations. BDNF levels can therefore be useful markers for clinical response or improvement of depressive symptoms, but they are not diagnostic markers of major depression.

Abstract

Neurotrophic factors are critical regulators of the formation and plasticity of neuronal networks. Brain-derived neurotrophic factor (BD-NF) is abundant in the brain and periphery, and is found in both human serum and plasma. Animal studies have demonstrated that stress reduces BDNF expression or activity in the hippocampus and that this reduction can be prevented by treatment with antidepressant drugs. A similar change in BDNF activity occurs in the brain of patients with major depression disorder (MDD). Recently, clinical studies have indicated that serum or plasma BDNF levels are decreased in untreated MDD patients. Antidepressant treatment for at least four weeks can restore the decreased BDNF function up to the normal value. Therefore, MDD is associated with impaired neuronal plasticity. Suicidal behavior can be a consequence of severe impaired neuronal plasticity in the brain. Antidepressant treatment promotes increased BDNF activity as well as several forms of neuronal plasticity, including neurogenesis, synaptogenesis and neuronal maturation. BDNF could also play an important role in the modulation of neuronal networks. Such a neuronal plastic change can positively influence mood or recover depressed mood. These alterations of BDNF levels or neuronal plasticity in MDD patients before and after antidepressant treatment can be measured through the examination of serum or plasma BDNF concentrations. BDNF levels can therefore be useful markers for clinical response or improvement of depressive symptoms, but they are not diagnostic markers of major depression.

참고문헌 (53)

  1. Warner-Schmidt JL, "Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment", Hippocampus, 16, pp.239~249 (2006)
  2. Mellstrom B, "The BDNF gene: exemplifying complexity in Ca2+ -dependent gene expression", Crit Rev Neurobiol, 16, pp.43~49 (2004)
  3. Lu B, "The yin and yang of neurotrophin action", Nat Rev Neurosci, 6, pp.603~614 (2005)
  4. Miller FD, "Neurotrophin signaling pathways regulating neu-ronal apoptosis", Cell Mol Life Sci, 58, pp.1045~1053 (2001)
  5. Duman RS, "Pathophysiology of depression: the concept of synaptic pla-sticity", Eur Psychiatry, 17(3), pp.306~310 (2002)
  6. Castrén E, "Role of neurotrophic factors in depression", Curr Opin Pharmacol, 7, pp.18~21 (2007)
  7. Smith MA, "Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neu-rotrophin-3 mRNAs in the hippocampus", J Neurosci, 15, pp.1768~1777 (1995)
  8. Ueyama T, "Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain", Neurosci Res, 28, pp.103~110 (1997)
  9. Rasmusson AM, "Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock", Neuropsychopharmacology, 27, pp.133~142 (2002)
  10. Pizarro JM, "Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice", Brain Res, 1025, pp.10~20 (2004)
  11. Roceri M, "Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus", Mol Psychiatry, 7, pp.609~616 (2002)
  12. Russo-Neustadt A, "Physical activity-antidepressant treatment combination: impact on brain-derived neurotro-phic factor and behavior in an animal model", Behav Brain Res, 120, pp.87~95 (2001)
  13. Schaaf MJ, "Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone", Brain Res, 813, pp.112~120 (1998)
  14. Dwivedi Y, "Antidepressants reverse corticosterone-mediated decrease in BDNF expression: dissociation in regulation of specific exons by antidepressants and corticosterone", Neuroscience, 139, pp.1017~1029 (2006)
  15. Chao HM, "Adrenal steroid regulation of neurotrophic factor expression in the rat hippocampus", Endocrinology, 139, pp.3112~3118 (1998)
  16. Tsankova NM, "Sustained hippocampal chromatin regulation in a mouse model of depres-sion and antidepressant action", Nat Neurosci, 9, pp.519~525 (2006)
  17. Duman RS, "A neurotrophic model for stress-related mood disorders", Biol Psychiatry, 59, pp.1116~1127 (2006)
  18. Müller MB, "Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain", Neuropsycho-pharmacology, 23, pp.205~215 (2000)
  19. Altar CA, "Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways", J Neurosci, 24, pp.2667~2677 (2004)
  20. Balu DT, "Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments", Brain Res, 1211, pp.37~43 (2008)
  21. Coppell AL, "Bi-phasic change in BDNF gene expression following antidepressant drug treatment", Neuropharmacology, 44, pp.903~910 (2003)
  22. De Foubert G, "Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment", Neuroscience, 128, pp.597~604 (2004)
  23. Altieri M, "Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after ch-ronic and acute antidepressant treatment", Brain Res, 1000, pp.148~155 (2004)
  24. Hajszan T, "Short-term treatment with the an-tidepressant fluoxetine triggers pyramidal dendritic spine synapse forResponse mation in rat hippocampus", Eur J Neurosci, 21, pp.1299~1303 (2005)
  25. Sairanen M, "Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat", Neuroscience, 144, pp.368~374 (2007)
  26. Saarelainen T, "Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects", J Neurosci, 23, pp.349~357 (2003)
  27. Monteggia LM, "Essential role of brain-derived neurotrophic factor in adult hippocampal function", Proc Natl Acad Sci U S A, 101, pp.10827~10832 (2004)
  28. Altar CA, "Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain", Biol Psychiatry, 54, pp.703~709 (2003)
  29. MacQueen GM, "Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression", Behav Neurosci, 115, pp.1145~1153 (2001)
  30. Zörner B, "Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than depressive", Biol Psychiatry, 54, pp.972~982 (2003)
  31. Chen B, "Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication", Biol Psychiatry, 50, pp.260~265 (2001)
  32. Dowlatshahi D, "Increased temporal cortex CREB concentrations and antidepressant treatment in major depression", Lancet, 352, pp.1754~1755 (1998)
  33. Fujimura H, "Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation", Thromb Haemost, 87, pp.728~734 (2002)
  34. Pan W, "Transport of brain-derived neurotrophic factor across the blood-brain barrier", Neuropharmacology, 37, pp.1553~1561 (1998)
  35. Poduslo JF, "Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF", Brain Res Mol Brain Res, 36, pp.280~286 (1996)
  36. Gonul AS, "Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients", Eur Arch Psychiatry Clin Neurosci, 255, pp.381~386 (2005)
  37. Karege F, "Decreased serum brain-derived neurotrophic factor levels in major depress-ed patients", Psychiatry Res, 109, pp.143~148 (2002)
  38. Karege F, "Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity", Biol Psychiatry, 57, pp.1068~1072 (2005)
  39. Shimizu E, "Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants", Biol Psychiatry, 54, pp.70~75 (2003)
  40. Lee BH, "Decreased plasma BDNF level in depressive patients", J Affect Disord, 101, pp.239~244 (2007)
  41. Brunoni AR, "A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression", Int J Neuropsychopharmacol, 11, pp.1169~1180 (2008)
  42. Yoshimura R, "Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.1034~1037 (2007)
  43. Matrisciano F, "Changes in BDNF serum levels in patients with depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine", J Psychiatr Res, 43, pp.247~254 (2009)
  44. Lee HY, "Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants", Neuropsychobiology, 57, pp.194~199 (2008)
  45. Piccinni A, "Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments", J Affect Disord, 105, pp.279~283 (2008)
  46. Dwivedi Y, "Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects", Arch Gen Psychiatry, 60, pp.804~815 (2003)
  47. Pandey GN, "Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims", Int J Neuropsychopharmacol, 11, pp.1047~1061 (2008)
  48. Ernst C, "Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers", Arch Gen Psychiatry, 66, pp.22~32 (2009)
  49. Dwivedi Y, "Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide", Biol Psychiatry, 65, pp.319~328 (2009)
  50. Deveci A, "Serum BDNF levels in suicide attempters related to psychosocial stressors: a comparative study with depression", Neuropsychobiology, 56, pp.93~97 (2007)
  51. Kim YK, "Low plasma BDNF is associated with suicidal behavior in depression", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.78~85 (2007)
  52. Dawood T, "Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness", Mol Psychiatry, 12, pp.981~983 (2007)
  53. Malcangio M, "A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors", Trends Pharmacol Sci, 24, pp.116~121 (2003)

관련 논문AI추천

Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive DisorderBun-Hee Lee, Young-Min Park대한신경정신의학회 · PSYCHIATRY INVESTIGATION2018 · 제15권 제8호우울증 환자의 혈액에서 측정되는 BDNF 농도 변화와 그 의미김용구, 이분희대한신경정신의학회 · 신경정신의학2009 · 제48권 제4호A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in SchizophreniaJimmy Lee, Milawaty Nurjono, Siow-Ann Chong대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2012 · 제10권 제2호Elevated Brain-Derived Neurotrophic Factor Levels During Depressive Mixed StatesHotaka Shinzato, Kazuhiro Kurihara, Kazuki Ota, Naoaki Otsuka, Tsuyoshi Kondo, Yoshikazu Takaesu, Yu Zamami대한신경정신의학회 · PSYCHIATRY INVESTIGATION2023 · 제20권 제11호Decreased Plasma BDNF Levels of Patients with Somatization Disorder강남인, 김용구, 박종일, 양종철대한신경정신의학회 · PSYCHIATRY INVESTIGATION2016 · 제13권 제5호Biomarkers of Major Depressive Disorder: Knowing is Half the BattleAkriti Dangol, Govind Arora, Ravinder Singh, Sahil Malik, Sanjay Goyal대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제1호

이 간행물의 다른 논문 (5건)

Epigenetic Regulation of BDNF Gene in Response to StressShiro Takei, Shigeto Yamamoto, Manabu Fuchikami, Shigeru Morinobu, Shigeto Yamawakipp. 251-256Thyroid Stimulating Hormone, Cognitive Impairment and Depression in an Older Korean Population양수진, 윤진상, 김선영, 배경열, 김성완, 신일선, 김재민, Robert Stewartpp. 264-269The Genetic Factors Affecting Drinking Behaviors of Korean Young Adults with Variant Aldehyde Dehydrogenase 2 Genotype김시경, 손정우, 주가원, 신철진, 이상익pp. 270-277Deficits in Facial Emotion Recognition in Schizophrenia: A Replication Study with Korean Subjects이승재, 이경욱, 이정태, 이해국, 권용실pp. 291-297Impaired Set-Shifting Ability in Patients with Eating Disorders, Which Is Not Moderated by Their Catechol-O-Methyltransferase Val158Met GenotypeMi Hyun Kim, Youl-Ri Kim, Ji Eun Kimpp. 298-301
원문 보기